Literature DB >> 15955318

Entamoeba histolytica: functional characterization of the -234 to -196 bp promoter region of the multidrug resistance EhPgp1 gene.

M Esther Ramirez1, D Guillermo Perez, Elvira Nader, Consuelo Gomez.   

Abstract

The multidrug resistance EhPgp1 gene is constitutively expressed in drug resistant trophozoites from Entamoeba histolytica. It has been demonstrated that two CCAAT/enhancer binding sites located in the EhPgp1 gene promoter control its transcriptional activation. However, functional assays of the 5' end of its promoter showed that region from -234 to -196 bp (38 bp) is also important for the EhPgp1 gene transcription. Here, we demonstrated that in the 38 bp region putative cis-activator sequences are located. In silico analysis showed the presence of GATA1, Gal4, Nit-2, and C/EBP consensus sequences. Additionally, we identified three specific DNA-protein complexes, which were competed by a C/EBP, GATA1, and HOX oligonucleotides. Finally, we partially purified three proteins of 64.4, 56.7, and 27.4 kDa. Further investigations are currently in progress to determine the identity of these nuclear factors and how they are interacting with the EhPgp1 gene promoter.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15955318     DOI: 10.1016/j.exppara.2005.03.011

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  3 in total

Review 1.  Regulation of gene expression in protozoa parasites.

Authors:  Consuelo Gomez; M Esther Ramirez; Mercedes Calixto-Galvez; Olivia Medel; Mario A Rodríguez
Journal:  J Biomed Biotechnol       Date:  2010-03-02

2.  EpiphaNet: An Interactive Tool to Support Biomedical Discoveries.

Authors:  Trevor Cohen; G Kerr Whitfield; Roger W Schvaneveldt; Kavitha Mukund; Thomas Rindflesch
Journal:  J Biomed Discov Collab       Date:  2010-09-21

3.  Structural and functional analysis of the Entamoeba histolytica EhrabB gene promoter.

Authors:  Mónica Romero-Díaz; Consuelo Gómez; Israel López-Reyes; Máximo B Martínez; Esther Orozco; Mario A Rodríguez
Journal:  BMC Mol Biol       Date:  2007-09-20       Impact factor: 2.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.